[1]CurrentPatentAssignee:MERCK&COINC-WO2008/76243,2008,A2Locationinpatent:Page/Pagecolumn42
[2]CurrentPatentAssignee:MERCK&COINC-WO2008/85316,2008,A1Locationinpatent:Page/Pagecolumn39
[1]CurrentPatentAssignee:MERCK&COINC-WO2008/76243,2008,A2Locationinpatent:Page/Pagecolumn42
[2]CurrentPatentAssignee:MERCK&COINC-WO2008/85316,2008,A1Locationinpatent:Page/Pagecolumn38-39
[3]CurrentPatentAssignee:MERCK&COINC-WO2018/118670,2018,A1Locationinpatent:Page/Pagecolumn121
1034827-56-9 
 
(2S,3R)-methyl3-cyclopropyl-2-methyl-3-(spirochroman-2,4’-piperidin-7-yl)propanoate 
 
(2S,3R)-methyl3-cyclopropyl-2-methyl-3-(1‘-(2-(trifluoromethyl)pyrimidin-4-yl)spirochroman-2,4’-piperidin-7-yl)propanoate 
[1]CurrentPatentAssignee:MERCK&COINC-WO2018/118670,2018,A1Locationinpatent:Page/Pagecolumn121;122
1034827-56-9 
 
(2S,3R)-methyl3-cyclopropyl-2-methyl-3-(spirochroman-2,4’-piperidin-7-yl)propanoate 
 
sodium(2S,3R)-3-cyclopropyl-2-methyl-3-(1‘-(2-(trifluoromethyl)pyrimidin-4-yl)spirochroman-2,4’-piperidin-7-yl)propanoate 
[1]CurrentPatentAssignee:MERCK&COINC-WO2018/118670,2018,A1
1034827-56-9 
 
N-(4-fluorophenyl)-5-(5,6,7,8-tetrahydro-1,5-naphthyridin-2-yl)spiro2.3hexane-5-carboxamide 
 
N-(4-fluorophenyl)-5-(5-(2-(trifluoromethyl)pyrimidin-4-yl)-5,6,7,8-tetrahydro-1,5-naphthyridin-2-yl)spiro2.3hexane-5-carboxamide 
[1]CurrentPatentAssignee:MERCK&COINC-WO2019/89412,2019,A1Locationinpatent:Page/Pagecolumn186;187